卫宁健康12月29日获融资买入5171.65万元，融资余额13.57亿元

Group 1 - The core viewpoint of the news is that Weining Health has experienced a decline in stock performance and financial metrics, indicating potential challenges in its business operations [1][2]. - As of December 29, Weining Health's stock price fell by 0.80%, with a trading volume of 400 million yuan. The net financing buy was -7.38 million yuan, indicating more repayments than new purchases [1]. - The financing balance of Weining Health reached 1.363 billion yuan, accounting for 7.09% of its market capitalization, which is above the 80th percentile of the past year [1]. Group 2 - For the period from January to September 2025, Weining Health reported a revenue of 1.296 billion yuan, a year-on-year decrease of 32.27%, and a net profit attributable to shareholders of -241 million yuan, a significant decline of 256.10% [2]. - The company has distributed a total of 455 million yuan in dividends since its A-share listing, with 97.23 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of Weining Health's shareholders decreased to 111,000, while the average circulating shares per person increased to 17,249 shares [2][3].